首页> 美国卫生研究院文献>Postgraduate Medical Journal >Non-steroidal anti-inflammatory drug ingestion: retrospective study of 272 bleeding or perforated peptic ulcers.
【2h】

Non-steroidal anti-inflammatory drug ingestion: retrospective study of 272 bleeding or perforated peptic ulcers.

机译:非甾体抗炎药的摄入:回顾性研究272例出血或消化性溃疡。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The ingestion of non-steroidal anti-inflammatory drugs (NSAID) in 272 patients with bleeding or perforated peptic ulcer was compared with 272 age/sex matched controls. A significantly higher proportion of patients with gastric ulcers had received NSAID than those with duodenal ulcers. Twelve of 90 (13%) patients admitted with bleeding duodenal ulcers had received NSAID compared with 11 of 26 (42%) patients with bleeding gastric ulcers (P = 0.003). Sixteen of 132 (12%) patients with perforated duodenal ulcer were taking NSAID compared with 8 of 24 (33%) patients with perforated gastric ulcer. Thirty eight percent of patients with both bleeding and perforated gastric ulcers had received NSAID compared with 13% bleeding and perforated duodenal ulcers (P less than 0.002). This study confirms the association of NSAID and complicated peptic ulcer in patients of over 65 years and highlights the particular susceptibility of the gastric mucosa to their injurious effect.
机译:将272例出血/穿孔性消化性溃疡患者的非甾体类抗炎药(NSAID)的摄入与272个年龄/性别匹配的对照组进行了比较。胃溃疡患者接受NSAID的比例明显高于十二指肠溃疡患者。接受十二指肠溃疡出血的90名患者中有十二名(13%)接受过NSAID,而发生胃溃疡出血的26名患者中有11名(42%)接受过NSAID(P = 0.003)。 132例十二指肠溃疡穿孔患者中有16名(12%)服用NSAID,而24例(33%)穿孔胃溃疡患者中有8名正在服用NSAID。有出血和穿孔性胃溃疡的患者中有38%接受过NSAID,而出血和穿孔性十二指肠溃疡的患者中有13%接受过NSAID(P小于0.002)。这项研究证实了65岁以上患者中NSAID与消化性溃疡的相关性,并强调了胃黏膜对其伤害作用的特殊敏感性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号